Thus, FGL1 blockade in liver tissues primarily affects the tumor microenvironment through the immunological regulation of CD8+ T and NK cells, which is a unique feature of liver tissue and may become an important means of inhibiting liver cancer. The gene discussed is CD8A; the disease is liver cancer.